Urteste SA Cash Flow Conversion Efficiency

Latest as of March 2026: -0.185x

Urteste SA cash flow conversion efficiency. Based on the latest financial reports, Urteste SA (URT) has a cash flow conversion efficiency ratio of -0.185x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-4.41 Million ≈ $-1.21 Million USD) by net assets (zł23.79 Million ≈ $6.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Urteste SA (2019–2025)

Cash flow conversion efficiency of Urteste SA from 2019 to 2025. This chart illustrates how Urteste SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Urteste SA for real-time trading data and today's change.

Urteste SA Cash Flow Conversion Ratio Explained

Urteste SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Urteste SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Urteste SA ranked by their cash flow conversion efficiency. Also see URT market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Rajshree Polypack Limited
NSE:RPPL
0.072x
Primega Group Holdings Limited Ordinary Shares
NASDAQ:PGHL
N/A
Kota Satu Properti Tbk PT
JK:SATU
0.014x
Wicaksana Overseas International
JK:WICO
0.087x
Zodiac Energy Limited
NSE:ZODIAC
-0.145x
Anoto Group AB
ST:ANOT
0.251x
Samyang Holdings Corp
KO:000075
0.036x
Superhouse Limited
NSE:SUPERHOUSE
0.110x

Annual Cash Flow Conversion Efficiency for Urteste SA (2019–2025)

The table below shows the annual cash flow conversion efficiency of Urteste SA from 2019 to 2025. Review free cash flow generation of Urteste SA to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 zł34.58 Million
≈ $9.52 Million
zł10.64 Million
≈ $2.93 Million
0.308x +235.68%
2024-12-31 zł24.11 Million
≈ $6.64 Million
zł-5.47 Million
≈ $-1.50 Million
-0.227x -18.22%
2023-12-31 zł27.74 Million
≈ $7.64 Million
zł-5.32 Million
≈ $-1.46 Million
-0.192x +71.57%
2022-12-31 zł5.62 Million
≈ $1.55 Million
zł-3.79 Million
≈ $-1.04 Million
-0.675x -154.05%
2021-12-31 zł9.69 Million
≈ $2.67 Million
zł-2.57 Million
≈ $-708.19K
-0.266x +73.22%
2020-12-31 zł1.37 Million
≈ $375.68K
zł-1.35 Million
≈ $-372.56K
-0.992x -197.46%
2019-12-31 zł1.20 Million
≈ $328.95K
zł-398.48K
≈ $-109.67K
-0.333x --

About Urteste SA

WAR:URT Poland Biotechnology
Market Cap
$17.22 Million
zł62.57 Million PLN
Market Cap Rank
#25442 Global
#258 in Poland
Share Price
zł41.00
Change (1 day)
-2.38%
52-Week Range
zł29.10 - zł70.20
All Time High
zł180.00
About

Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.